February’s plunge in consumer confidence marks the third consecutive month-on-month decline, a concerning trend given that ...

Research analysts at HC Wainwright lowered their Q1 2025 earnings estimates for shares of Fulcrum Therapeutics in a report released on Wednesday, February 26th. HC Wainwright analyst A. Fein now ...

Teleperformance's 2024 results show solid growth, healthy cash flow, and focus on debt reduction. See why I think long-term ...

Economic growth in Asia's third-largest economy slowed sharply this fiscal year as high inflation and stagnant incomes ...

Outlook Therapeutics (NASDAQ:OTLK – Get Free Report) had its price target reduced by research analysts at Ascendiant Capital Markets from $33.00 to $24.00 in a research note issued to investors on ...

Americans are growing more uneasy about the economy, and Wall Street is feeling the jitters. Stocks fell on the report - ...

Consumers grew more pessimistic about the economic outlook in February as worries brewed about a slowing economy and rising ...

Canada's Bank of Nova Scotia and Bank of Montreal said on Tuesday they would wait for clarity on U.S. government tariffs to ...

Shares sagged Tuesday in Asia as worries over U.S.-China trade friction weighed on the outlook for the region.

There's little data that could shock market participants out of their current mood before March 7-12, and "it's possible we stay in a generally pessimistic outlook," strategist says.

“Optimism is limited as the danger of miscalculation or misjudgment by political and military actors is high,” 2025 Global ...